Mental Depression
|
0.350 |
Biomarker
|
disease |
BEFREE |
First, we performed a quantitative investigation using FACT-B (Chinese version) and Irritability, Depression and Anxiety scale (IDA) to assess the QOL and PS in breast cancer patients who received BRCA1/2 genetic testing.
|
27428375 |
2016 |
Mental Depression
|
0.350 |
Biomarker
|
disease |
PSYGENET |
On hierarchical regression analysis, in women with a positive BRCA1/2 result (vs NU or UV), a lower perceived probability of cancer genetic predisposition than objective estimates at T1 predicted lower levels of anxiety at T2 (β=-0.28; P<0.01), whereas in women receiving a UV result (vs NU or positive BRCA1/2), a lower perceived probability of cancer genetic predisposition than objective estimates at T1 predicted higher levels of anxiety (β=0.20; P<0.01), depression (β=0.19; P<0.05) and intrusion (β=0.18; P<0.05) at T2.
|
23462725 |
2013 |
Mental Depression
|
0.350 |
GeneticVariation
|
disease |
BEFREE |
On hierarchical regression analysis, in women with a positive BRCA1/2 result (vs NU or UV), a lower perceived probability of cancer genetic predisposition than objective estimates at T1 predicted lower levels of anxiety at T2 (β=-0.28; P<0.01), whereas in women receiving a UV result (vs NU or positive BRCA1/2), a lower perceived probability of cancer genetic predisposition than objective estimates at T1 predicted higher levels of anxiety (β=0.20; P<0.01), depression (β=0.19; P<0.05) and intrusion (β=0.18; P<0.05) at T2.
|
23462725 |
2013 |
Mental Depression
|
0.350 |
Biomarker
|
disease |
PSYGENET |
Two hundred and nine women with uninformative BRCA1/2 test results completed questionnaires at pretesting and 1-, 6-, and 12-month post-disclosure, including measures of anxiety and depression, cancer-specific and genetic testing distress.
|
19214961 |
2009 |
Mental Depression
|
0.350 |
Biomarker
|
disease |
BEFREE |
To predict which women might suffer from abnormally high levels of anxiety and depression after receiving a positive genetic BRCA1 test result, series of pregenetic testing and postgenetic testing psychological measurements were performed.
|
19405874 |
2009 |
Mental Depression
|
0.350 |
Biomarker
|
disease |
PSYGENET |
To predict which women might suffer from abnormally high levels of anxiety and depression after receiving a positive genetic BRCA1 test result, series of pregenetic testing and postgenetic testing psychological measurements were performed.
|
19405874 |
2009 |
Mental Depression
|
0.350 |
Biomarker
|
disease |
PSYGENET |
Compared to mutation carriers for BRCA1, the level of anxiety and depression was significantly higher in the FBOC group with absence of demonstrated mutation.
|
15951962 |
2005 |
Mental Depression
|
0.350 |
AlteredExpression
|
disease |
BEFREE |
Compared to mutation carriers for BRCA1, the level of anxiety and depression was significantly higher in the FBOC group with absence of demonstrated mutation.
|
15951962 |
2005 |
Mental Depression
|
0.350 |
GeneticVariation
|
disease |
BEFREE |
In BRCA1/2-linked families, persons with high levels of cancer-related stress who decline genetic testing may be at risk for depression.
|
9586874 |
1998 |
Mental Depression
|
0.350 |
Biomarker
|
disease |
PSYGENET |
In BRCA1/2-linked families, persons with high levels of cancer-related stress who decline genetic testing may be at risk for depression.
|
9586874 |
1998 |